NCT06360627Recruiting
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Summary
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Inclusion criteria
• CT SCAN for pulmonary nodule detection/follow up • CT SCAN for pneumonia detection/follow up
Exclusion criteria
• under 18 • BMI over 30
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- University of Zurich(Other)
- Protocol no.
- 2022_D0008
- Conditions
- Radiation Exposure, Lung Embolism, Lung Cancer, Pneumonia
- Interventions
- Radiation
Treatments studied
- Computed Tomography
Locations · 1
- Zurich, SwitzerlandUniversity Hospital Zurich - Diagnostic RadiologyRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: April 11, 2024).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.